scispace - formally typeset
Journal ArticleDOI

Graphene Quantum Dots-Capped Magnetic Mesoporous Silica Nanoparticles as a Multifunctional Platform for Controlled Drug Delivery, Magnetic Hyperthermia, and Photothermal Therapy.

TLDR
The results indicate that compared with chemotherapy, magnetichyperthermia or photothermal therapy alone, the combined chemo-magnetic hyperthermia therapy or chemo -photothermal therapy with the DOX-loaded MMSN/GQDs nanosystem exhibits a significant synergistic effect, resulting in a higher efficacy to kill cancer cells.
Abstract
A multifunctional platform is reported for synergistic therapy with controlled drug release, magnetic hyperthermia, and photothermal therapy, which is composed of graphene quantum dots (GQDs) as caps and local photothermal generators and magnetic mesoporous silica nanoparticles (MMSN) as drug carriers and magnetic thermoseeds. The structure, drug release behavior, magnetic hyperthermia capacity, photothermal effect, and synergistic therapeutic efficiency of the MMSN/GQDs nanoparticles are investigated. The results show that monodisperse MMSN/GQDs nanoparticles with the particle size of 100 nm can load doxorubicin (DOX) and trigger DOX release by low pH environment. Furthermore, the MMSN/GQDs nanoparticles can efficiently generate heat to the hyperthermia temperature under an alternating magnetic field or by near infrared irradiation. More importantly, breast cancer 4T1 cells as a model cellular system, the results indicate that compared with chemotherapy, magnetic hyperthermia or photothermal therapy alone, the combined chemo-magnetic hyperthermia therapy or chemo-photothermal therapy with the DOX-loaded MMSN/GQDs nanosystem exhibits a significant synergistic effect, resulting in a higher efficacy to kill cancer cells. Therefore, the MMSN/GQDs multifunctional platform has great potential in cancer therapy for enhancing the therapeutic efficiency.

read more

Citations
More filters
Journal ArticleDOI

Controlling Morphology and Release Behavior of Sorafenib-Loaded Nanocarriers Prepared by Flash Nanoprecipitation

TL;DR: This work prepared stable sorafenib-loaded NPs with biocompatible amphiphilic poly(ethylene glycol)-block-poly(lactide acid) (PEG-b-PLA) as stabilizing polymer based on FNP to show well-controlled size and high drug loading content compared with nanoparticles from traditional antisolvent precipitation.
Journal ArticleDOI

Preparation of organic-modified magadiite–magnetic nanocomposite particles as an effective nanohybrid drug carrier material for cancer treatment and its properties of sustained release mechanism by Korsmeyer–Peppas kinetic model

TL;DR: In this paper, the nanoparticles Fe3O4 were supported on cetyltrimethyl ammonium-bromide (CTAB)-modified magadiite by coprecipitation method to prepare magnetic composite particles, which exhibited high drug loading capacity up to 123.98 mg/g of binding anticancer drug 5-fluorouracil (5-FU).
Journal ArticleDOI

Functionalized graphene oxide/Fe3O4 nanocomposite: A biocompatible and robust nanocarrier for targeted delivery and release of anticancer agents.

TL;DR: In this paper, a simple approach was used for the synthesis of superparamagnetic graphene oxide (SPMGO) nanocomposite through a chemical precipitation method, which was readily functionalized with cyanuric chloride as a linker for loading the drug.
Journal ArticleDOI

Magnetic Particle Bioconjugates: A Versatile Sensor Approach

TL;DR: In this article, the authors highlight the evergrowing applications of magnetic materials for the detection of analytes present in various real sample matrices, and show the versatility and advantages of using magnetic particles for a variety of sample matrix and analyte types and the adaptability of different transducers with the magnetic particle approaches.
Journal ArticleDOI

Were magnetic materials useful in cancer therapy

TL;DR: Magnetic nanoparticles have been also designed for utilizing as contrast enhancer agents for magnetic resonance imaging, drug delivery systems, and most recently as a therapeutic element in inducing cellular death in tumor ablation therapies.
References
More filters
Journal ArticleDOI

A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules.

TL;DR: An MCM-41 type mesoporous silica nanosphere-based controlled-release delivery system has been synthesized and characterized using surface-derivatized cadmium sulfide nanocrystals as chemically removable caps to encapsulate several pharmaceutical drug molecules and neurotransmitters inside the organically functionalized MSN Mesoporous framework.
Journal ArticleDOI

Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery

TL;DR: Potential opportunities for the combination of hyperthermia-based therapy and controlled drug release paradigms--towards successful application in personalized medicine are portrayed.
Journal ArticleDOI

Functionalized mesoporous silica materials for controlled drug delivery

TL;DR: This review highlights the most recent research progress on silica-based controlled drug delivery systems, including pure mesoporous silica sustained-release systems, magnetism and/or luminescence functionalized mesoporus silica systems which integrate targeting and tracking abilities of drug molecules.
Journal ArticleDOI

Unusual infrared-absorption mechanism in thermally reduced graphene oxide

TL;DR: The observation of a giant-infrared-absorption band in reduced graphene oxide is reported, arising from the coupling of electronic states to the asymmetric stretch mode of a yet-unreported structure, consisting of oxygen atoms aggregated at the edges of defects.
Journal ArticleDOI

Multifunctional Mesoporous Silica-Coated Graphene Nanosheet Used for Chemo-Photothermal Synergistic Targeted Therapy of Glioma

TL;DR: These findings provided an excellent drug delivery system for combined therapy of glioma due to the advanced chemo-photothermal synergistic targeted therapy and good drug release properties of GSPID, which could effectively avoid frequent and invasive dosing and improve patient compliance.
Related Papers (5)